This serum is typically used in 12-week cycles, followed by a break of at least 2 weeks before restarting
Although patients at risk for diabetes (ie, prediabetes, defined as a hemoglobin A1C 5.7% to 6.4% or a fasting blood glucose level 100 to 125 mg/dL) were included in FDA registration trials of Saxenda or Wegovy, prediabetes is not an FDA indication for any GLP-1 agonist
In a 12-month retrospective study of 339 Second Nature members published in JMIR Formative Research, participants on tirzepatide lost an average of 22.1% of their body weight, and those on semaglutide lost 17.1% 5
Before starting any dose level, discuss your medical history, current medications, and any previous adverse reactions with your healthcare provider
Most peptides are destroyed in the digestive system, which is why injectable forms dominate the market
For those tracking their tirzepatide results and comparing them to expected retatrutide outcomes, the transition data from the clinical trials provides useful benchmarks
